Geoff’s Narration The GIST For me the risk is small and the (potential) benefit is huge. Dr. Kaufman We’re back, focusing on GLP-1-enhancing drugs. Why another GLP-1 blog? Because new information keeps pouring out. Plus, these surprise drugs constitute perhaps the most exciting treatment possibility ever seen in ME/CFS, […] The post The GLP-1 Agonist Boom in ME/CFS, FM and Long COVID: Insights, Using it, Trials Underway appeared first on Health Rising.| Health Rising
Geoff’s Narration The GIST This is the next in a series of blogs exploring ongoing projects in ME/CFS, FM and long COVID. The first featured the RECOVER project’s next set of long COVID clinical trials. RECOVER’s 2nd Round of Long COVID Clinical Trials Shows Progress… and Limitations I gaped […] The post PrecisionLife’s Bold Attempt to Break the Code on and Beat ME/CFS and Long COVID appeared first on Health Rising.| Health Rising
Geoff’s Narration The GIST Just months after the publication of the first large ME/CFS GWAS study comes an enormous FM GWAS study. Notice how these two diseases seem to be marching hand in hand. Both are greatly underfunded, both are still struggling for recognition in some circles, symptoms define […] The post The Brain Disease: Huge Fibromyalgia Genetic Study Highlights the Brain and Offers New Treatment Possibilities appeared first on Health Rising.| Health Rising
Geoff’s Translation The GIST “With this breakthrough, we are proud to enable a first-in-class test that can address an unmet need for a quick and reliable diagnostic for a complex, challenging-to-identify illness,” said Oxford Biodynamics’ Chief Scientific Officer Alexandre Akoulitchev. We live in creative times. The number of clever […] The post New Epigenetic Diagnostic Test For ME/CFS Wows … But Can It Hold? appeared first on Health Rising.| Health Rising
Geoff’s Narration The GIST This is the first of a series of blogs on ongoing projects in ME/CFS, long COVID, etc. We’re back focused on the “Treating Long COVID” portion of the NIH’s RECOVER project for long COVID. Why cover RECOVER? Because with about $1.8 billion to its name, […] The post RECOVER’s 2nd Round of Long COVID Clinical Trials Shows Progress… and Limitations appeared first on Health Rising.| Health Rising
Geoff’s Narration The GIST Mestinon has done it again. Another study has shown that in the short term, at least, Mestinon can move the needle on two factors, energy production and strength, that are in short supply in ME/CFS. This study assessed handgrip strength. What, you might ask, could […] The post Exertion Enhancer? Mestinon (Again) Moves the Needle on a Key Marker in ME/CFS appeared first on Health Rising.| Health Rising
I owned a specialty food shop when my life was upended by ME/CFS, forcing me to completely reinvent myself and my relationship with food. My debut cookbook, In Good Health (out now in the US, out November 13th in the UK and Europe), was written—literally—from bed, after discovering I could […] The post In Good Health: How Chronic Illness Redefined My Relationship with Food appeared first on Health Rising.| Health Rising
If I could wish for anything, it might be something (besides caffeine) that leaves me more alert and functioning better cognitively during the daytime. Stimulants are one possibility. They can be very helpful in these diseases (blog is coming up), but they have their drawbacks. But how about a stimulating […] The post A Wake-Up Call for ME/CFS? The Solriamfetol / Sunosi Trial Improves Daytime Fatigue and Cognition appeared first on Health Rising.| Health Rising
Geoff’s Translation The GIST This is part one of a series of blogs on the Mast Cell Masterminds Conference, which took place in September 2024 in Fort Hood, Oregon. Thanks to Dr. Kaufman and the conference organizers for making it possible for me to view the presentations. One thing […] The post Mast Cell Masterminds #1: The Pelvic Venous Syndromes and ME/CFS, POTS, and long COVID appeared first on Health Rising.| Health Rising
Geoff’s Narration The GIST From viral persistence to complex immune studies, to tissue sampling, to assessing heavy-duty immune treatment trials and large treatment trials, long-COVID researchers are doing things the ME/CFS community has wanted to happen for decades. On the flip side, long-COVID researchers have acknowledged that early on, […] The post Is the Long COVID Field Missing a Major Opportunity? appeared first on Health Rising.| Health Rising
Health Rising provides the latest treatment and research information for fibromyalgia and chronic fatigue syndrome (ME/CFS)| Health Rising
The findings from a seminal (and massive) NIH intramural study done on chronic fatigue syndrome (ME/CFS) were explained during a symposium.| Health Rising